| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/18/2009 | EP1569635B1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 02/18/2009 | EP1539727B1 Compounds, compositions, and methods for treating cellular proliferative diseases |
| 02/18/2009 | EP1513519B1 The use of substituted cyanopyrrolidines for treating hyperlipidemia |
| 02/18/2009 | EP1513493B1 Analgesics |
| 02/18/2009 | EP1501530B1 Prostaglandin f2 alpha analogs in combination with antimicrobial for treating glaucoma |
| 02/18/2009 | EP1497265B1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 02/18/2009 | EP1494657A4 Removable anchored lung volume reduction devices and methods |
| 02/18/2009 | EP1463563B1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 02/18/2009 | EP1448281B1 Therapeutic coating for an intravascular implant |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1392298B1 Fused heterocyclic compounds |
| 02/18/2009 | EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 02/18/2009 | EP1218039B1 Use of high citrate dialysate |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | EP1084137B1 Peptide inhibitors of hepatitis c virus ns3 protease |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | EP0969866B2 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 02/18/2009 | EP0842143B3 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives |
| 02/18/2009 | EP0812184B2 Nitric oxide synthase inhibitors for topical use |
| 02/18/2009 | CN101371142A Method of diagnosis and method of treatment |
| 02/18/2009 | CN101370818A RNAi inhibition of influenza virus replication |
| 02/18/2009 | CN101370816A Crystalline form of 1¡ä-(1-methylethyl)- 4¡ä-[(2-fluoro-4-methoxyphenyl)methyl]-5¡ä-methyl-1h-pyrazol-3¡ä-o-beta-d-glucopyranoside, a method for its preparation and the use thereof for preparing medic |
| 02/18/2009 | CN101370814A Solid forms of a pyrrolopyrimidine derivative and their use as anti-tumor agents |
| 02/18/2009 | CN101370813A Dimers and adducts of 6-[substituted) phenyl] triazolopyrimidines useful as anticancer agents |
| 02/18/2009 | CN101370812A Fused heterocyclic compound |
| 02/18/2009 | CN101370811A Imidazopyrazines as protein kinase inhibitors |
| 02/18/2009 | CN101370809A Novel diazabicycloalkane derivatives and their medical use |
| 02/18/2009 | CN101370807A Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of alzheimer's disease via GABA receptors |
| 02/18/2009 | CN101370806A Substituted 4-phenylpiperidines |
| 02/18/2009 | CN101370805A Novel pyridine derivatives |
| 02/18/2009 | CN101370804A Aminophenyl derivatives as novel inhibitors of histone deacetylase |
| 02/18/2009 | CN101370803A Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370802A Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 02/18/2009 | CN101370801A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/18/2009 | CN101370800A Sulphur-containing cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/18/2009 | CN101370799A Cis-4, 5-biaryl-2-heterocyclic-imidazolines as MDM2 inhibitors |
| 02/18/2009 | CN101370796A Thiazoles as 11 beta-HSD1 inhibitors |
| 02/18/2009 | CN101370794A Chemical compounds |
| 02/18/2009 | CN101370793A Novel N-(fluoro-pyrazinyl)-phenylsulfonamid.es as moodulators of chemokine receptor CCR4 |
| 02/18/2009 | CN101370792A Bi-aryl meta-pyrimidine inhibitors of kinases |
| 02/18/2009 | CN101370791A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370790A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370789A Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/18/2009 | CN101370787A 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors |
| 02/18/2009 | CN101370784A Polycyclic indazole derivatives that are erk inhibitors |
| 02/18/2009 | CN101370783A Salts of 1-alkylamino-1-desoxypolyols with 9-oxoacridine-10-acetic acid, medicinal preparations on their base, their use, preventive measures and treatment |
| 02/18/2009 | CN101370782A Alkylsulphonamide quinolines |
| 02/18/2009 | CN101370780A Organic compound |
| 02/18/2009 | CN101370779A Cyclohexyl sulfonamide derivatives having H3 receptor activity |
| 02/18/2009 | CN101370775A Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors |
| 02/18/2009 | CN101370774A Crystal form of atorvastatin hemi-calcium and processes for preparation thereof |
| 02/18/2009 | CN101370773A Cycloalkanecarboxamide derivative and method for producing same |
| 02/18/2009 | CN101370771A Dibenzene derivatives as calcium channel blockers |
| 02/18/2009 | CN101370555A Novel use of (-)-epigallocatechin gallate |
| 02/18/2009 | CN101370536A Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood |
| 02/18/2009 | CN101370522A Specific therapy using integrin ligands for treating cancer |
| 02/18/2009 | CN101370520A Pharmaceutical composition for prevention or treatment of cardiac failure |
| 02/18/2009 | CN101370519A Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or Flt1 antagonist for treating cancer |
| 02/18/2009 | CN101370508A Compositions comprising kakadu plum extract or acai berry extract |
| 02/18/2009 | CN101370507A Therapeutic drug for traumatic neural disease (disorder) and/or motor function disorder |
| 02/18/2009 | CN101370506A Treatment of barrett's esophagus |
| 02/18/2009 | CN101370505A Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema |
| 02/18/2009 | CN101370504A Long term treatment of HIV- infection with TCM278 |
| 02/18/2009 | CN101370503A Use of a combination of morphine and at least one opiate antagonist for treatment of opiate dependency and for prevention of non-oral opiate abuse in opiate addicts |
| 02/18/2009 | CN101370502A Use of naphthyridine derivatives as medicaments |
| 02/18/2009 | CN101370501A Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 02/18/2009 | CN101370500A Use of 2-imidazoles for the treatment of CNS disorders |
| 02/18/2009 | CN101370499A Combination of ACHE inhibitor and 5-HT6 antagonist for the treatment of cognitive dysfunction |
| 02/18/2009 | CN101370498A Targeting GLI proteins in human cancer by small molecules |
| 02/18/2009 | CN101370497A Combination therapy with PARP inhibitors |
| 02/18/2009 | CN101370496A Novel thiophene derivatives as S1P1/EDG1 receptor agonists |
| 02/18/2009 | CN101370495A Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder |
| 02/18/2009 | CN101370494A Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| 02/18/2009 | CN101370493A Hydronol preparation |
| 02/18/2009 | CN101370492A Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
| 02/18/2009 | CN101370491A Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
| 02/18/2009 | CN101370490A Compositions and methods for preventing or treating inflammatory bowel disease |
| 02/18/2009 | CN101370489A Use of alkanedicarboxylic acids and retinoids for treatment of rosacea and other inflammatory skin diseases |
| 02/18/2009 | CN101370488A Compositions and methods for increasing insulin sensitivity |
| 02/18/2009 | CN101370485A Dosage form and method for the delivery of drugs of abuse |
| 02/18/2009 | CN101370484A Solid pharmaceutical composition comprising irbesartan |
| 02/18/2009 | CN101370478A Foam-forming composition |
| 02/18/2009 | CN101370476A Pharmaceutical composition and process |
| 02/18/2009 | CN101370396A Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 02/18/2009 | CN101370395A Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 02/18/2009 | CN101370380A Chemical compounds |
| 02/18/2009 | CN101368180A Small RNA numerator for differentiation of mesenchyma stem cell into hematopoiesis cell and function target point thereof |
| 02/18/2009 | CN101367879A Gastrodia elata polysaccharide, its sulfating derivant, preparation and application thereof |
| 02/18/2009 | CN101367869A Polypeptide for preventing, diagnosing and treating hepatitis E virus, and vaccine as diagnosis agent of the same |
| 02/18/2009 | CN101367861A 2-hydroxyl-3-deoxidized pentacyclic triterpenoid and derivant, preparation method and uses thereof |
| 02/18/2009 | CN101367859A Fatty acid bile acid couplet and medical uses thereof |
| 02/18/2009 | CN101367856A Methods and compositions for treating hepatitis c virus |
| 02/18/2009 | CN101367854A Macrolides with antibacterial activity |
| 02/18/2009 | CN101367853A 13-membered azalides and their use as antibiotic agents |
| 02/18/2009 | CN101367851A Oligosaccharide derivative |
| 02/18/2009 | CN101367850A Norabieta cantharidin derivant and synthesis thereof |
| 02/18/2009 | CN101367841A Compound with latent antitumor effect and method of preparing the same |
| 02/18/2009 | CN101367840A Phosphine isocoumarin amide, synthesis and uses thereof |
| 02/18/2009 | CN101367834A Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |